161 related articles for article (PubMed ID: 33146700)
1. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
Chen B; Zhang S; Li Q; Wu S; He H; Huang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
[TBL] [Abstract][Full Text] [Related]
2. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
[TBL] [Abstract][Full Text] [Related]
3. Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma.
Barrio-Alonso C; Nieto-Valle A; García-Martínez E; Gutiérrez-Seijo A; Parra-Blanco V; Márquez-Rodas I; Avilés-Izquierdo JA; Sánchez-Mateos P; Samaniego R
J Pathol; 2024 Apr; 262(4):495-504. PubMed ID: 38287901
[TBL] [Abstract][Full Text] [Related]
4. From Cellular Infiltration Assessment to a Functional Gene Set-Based Prognostic Model for Breast Cancer.
Li H; Huang Y; Sharma A; Ming W; Luo K; Gu Z; Sun X; Liu H
Front Immunol; 2021; 12():751530. PubMed ID: 34691065
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognosis analysis of GINS subunits in human breast cancer.
Li H; Cao Y; Ma J; Luo L; Ma B
Medicine (Baltimore); 2021 Mar; 100(11):e24827. PubMed ID: 33725952
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA sequencing reveals recruitment of the M2-like CCL8
Yang H; Lei Z; He J; Zhang L; Lai T; Zhou L; Wang N; Tang Z; Sui J; Wu Y
J Transl Med; 2024 Mar; 22(1):306. PubMed ID: 38528587
[TBL] [Abstract][Full Text] [Related]
7.
Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
[TBL] [Abstract][Full Text] [Related]
8. A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes.
Li X; Rouchka EC; Brock GN; Yan J; O'Toole TE; Tieri DA; Cooper NGF
PLoS One; 2018; 13(8):e0201813. PubMed ID: 30089167
[TBL] [Abstract][Full Text] [Related]
9. PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification.
He T; Sun X; Wu C; Yao L; Zhang Y; Liu S; Jiang Y; Li Y; Wang M; Xu Y
Cell Signal; 2023 Dec; 112():110918. PubMed ID: 37827342
[TBL] [Abstract][Full Text] [Related]
10. Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
Rakha EA; Soria D; Green AR; Lemetre C; Powe DG; Nolan CC; Garibaldi JM; Ball G; Ellis IO
Br J Cancer; 2014 Apr; 110(7):1688-97. PubMed ID: 24619074
[TBL] [Abstract][Full Text] [Related]
11. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
Qin W; Li J; Gao N; Kong X; Guo L; Chen Y; Huang L; Chen X; Qi F
Mol Cancer; 2024 May; 23(1):99. PubMed ID: 38730464
[TBL] [Abstract][Full Text] [Related]
12. Prediction of breast cancer proteins involved in immunotherapy, metastasis, and RNA-binding using molecular descriptors and artificial neural networks.
López-Cortés A; Cabrera-Andrade A; Vázquez-Naya JM; Pazos A; Gonzáles-Díaz H; Paz-Y-Miño C; Guerrero S; Pérez-Castillo Y; Tejera E; Munteanu CR
Sci Rep; 2020 May; 10(1):8515. PubMed ID: 32444848
[TBL] [Abstract][Full Text] [Related]
13. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients.
Pereira-Veiga T; Bravo S; Gómez-Tato A; Yáñez-Gómez C; Abuín C; Varela V; Cueva J; Palacios P; Dávila-Ibáñez AB; Piñeiro R; Vilar A; Chantada-Vázquez MDP; López-López R; Costa C
Mol Cell Proteomics; 2022 Dec; 21(12):100435. PubMed ID: 36519745
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment.
Xiong H; Chen Z; Lin B; Chen W; Li Q; Li Y; Fang M; Wang Y; Zhang H; Lu Y; Bi A; Wu S; Jia Y; Wang X
Mol Ther Oncolytics; 2022 Mar; 24():371-384. PubMed ID: 35118194
[TBL] [Abstract][Full Text] [Related]
15. Editorial: New progress in cancer biomarkers and therapy.
Sun G; He C; Wang J
Front Mol Biosci; 2024; 11():1388872. PubMed ID: 38516189
[No Abstract] [Full Text] [Related]
16. Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer.
Yang L; Cui Y; Huang T; Sun X; Wang Y
Onco Targets Ther; 2020; 13():11669-11688. PubMed ID: 33235459
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.
Ye Q; Han X; Wu Z
Bioengineered; 2020 Dec; 11(1):1280-1300. PubMed ID: 33164640
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
